Module 3: Immune Checkpoint Inhibitors in Immunocompromised Patients with NMSC
Primary Audience:
This activity is intended to meet the educational needs of a diverse group of care providers involved in the care of patients with high risk NMSC, including dermatologists, oncologists, radiation oncologists, Mohs surgeons, ENT and plastic surgeons.
Associate Professor
Emory Healthcare
Dr. Travis W. Blalock’s primary focus is Dermatological Surgery, including the treatment of skin cancers with a specialized surgical procedure called Mohs Micrographic Surgery. This procedure is used to treat multiple different skin cancers, including Basal Cell Carcinoma, squamous cell carcinoma, Merkel Cell Carcinoma, Sebaceous Carcinoma, and Dermatofibrosarcoma Protuberans, as well as many other types of skin cancer. Additionally, Dr. Blalock does surgery for other skin growths/lesions, skin reconstruction, and laser therapy of skin conditions.
Dr. Blalock is originally from Dallas, Georgia. He received his undergraduate degree from Emory College in Religion and received Emory University’s First Minor in Ethics. He graduated from Mercer University School of Medicine in Macon, Ga. Thereafter, he completed his internship in General Surgery at the University of Tennessee at Chattanooga in Chattanooga, Tennessee. He subsequently completed a residency in dermatology at the Medical College of Georgia in Augusta, GA, where he also served as Chief Resident in his final year. Following training in Dermatology, Dr. Blalock completed a Fellowship in Mohs Micrographic Surgery and Procedural Dermatology at Scripps Clinic in La Jolla, California.
Senior Physician, Dana-Farber Cancer Center
Assistant Professor of Medicine
Harvard Medical School
Dr. Justine V. Cohen is an oncologist in Boston, Massachusetts and is affiliated with Dana-Farber Cancer Institute. She received her medical degree from Philadelphia College of Osteopathic Medicine and has been in practice between 11-20 years. She has expertise in treating lung cancer, chronic leukemia, breast cancer, among other conditions.
Associate Professor of Dermatology and Pathology
Saint Louis University/SSM Health
Dr. Emily Smith is a dermatologist and dermatopathologist who cares for children and adults. She offers general dermatology services and performs skin exams and skin cancer screenings. She has expertise in the diagnosis and management of high-risk skin cancer (including melanoma, squamous cell carcinoma, and Merkel cell carcinoma), skin cancer in immunosuppressed patients, pigmented skin lesions, and skin toxicities associated with anti-cancer therapies. She runs a supportive oncodermatology and cutaneous oncology clinic at the cancer center.
As a dermatopathologist, Dr. Smith plays a pivotal role in the skin pathology process, receiving a patient's biopsied skin specimen, examining the tissue, and then making the official diagnosis.
Dr. Smith's research interests include melanoma, pigmented skin lesions, high-risk/complex cutaneous oncology, supportive oncodermatology, and clinicopathologic correlation.
Dr. Smith is an associate professor with the Division of Dermatology in the Department of Dermatology at Saint Louis University School of Medicine.
